Today's Low | Today's High | |
---|---|---|
835.00 835.00 |
| 923.50 922.05 |
52 Week Low | 52 Week High | |
---|---|---|
296.80 (26-Oct-2023) 296.45 (26-Oct-2023) |
| 959.50 (18-Sep-2024) 959.95 (18-Sep-2024) |
Buy Order Quantity | Sell Order Quantity | |
---|---|---|
543 | 0 |
Bid Price | Quantity |
---|---|
848.05 | 543.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | 543 |
Ask Price | Quantity |
---|---|
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
0.00 | 0.00 |
Total: | -- |
Market Cap: | ₹83.13 Cr |
PE Ratio (TTM): | 186.68 |
PB Ratio: | 4.13 |
Industry P/E: | 184.43 |
Debt to Equity: | - |
ROE: | 2.21 |
EPS (TTM): | 4.85 |
Book Value: | 235.66 |
Face Value: | 1.00 |
Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
---|---|---|---|---|---|
Revenue | 74.61 Cr | 83.74 Cr | 66.50 Cr | 51.64 Cr | 68.73 Cr |
Profit | 6.60 Cr | 7.90 Cr | -28.93 Cr | -4.79 Cr | -17.17 Cr |
Expense | 85.17 Cr | 87.42 Cr | 98.85 Cr | 80.80 Cr | 110.01 Cr |
Comprehensive income | 6.60 Cr | 7.90 Cr | -28.93 Cr | -4.79 Cr | -17.17 Cr |
EPS | 0.76 | 0.91 | -3.33 | -0.55 | -1.98 |
Company name | Listing date | Industry | NSE symbol BSE symbol |
---|---|---|---|
Shilpa Medicare Limited | Dec, 2009 Jun, 1995 | Pharmaceuticals Pharmaceuticals | SHILPAMED SHILPAMED |
Promoters | |
---|---|
50.01% |
Public | |
---|---|
49.99% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
50.01% |
Public | |
---|---|
49.99% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
50.01% |
Public | |
---|---|
49.99% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
50.01% |
Public | |
---|---|
49.99% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Promoters | |
---|---|
50.01% |
Public | |
---|---|
49.99% |
Shares held by Employee Trusts | |
---|---|
0.00% |
Today's stock performance witnessed a fluctuation from a minimum of 835.00 on the NSE (National Stock Exchange) to a maximum of 923.50. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 835.00 to a high of 922.05.
The stock's performance over the past 52 weeks reveals a low of 296.80 (occurred on 26-Oct-2023) and a high of 959.50 (achieved on 18-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 296.45 (on 26-Oct-2023), and the 52-week high is 959.95 (on 18-Sep-2024).
The stock's performance over the past 52 weeks reveals a low of 296.80 (occurred on 26-Oct-2023) and a high of 959.50 (achieved on 18-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 296.45 (on 26-Oct-2023), and the 52-week high is 959.95 (on 18-Sep-2024).
The total volume is 8, and the total traded value is 67.77 (₹ Lakhs).
The upper circuit limit is 1,082.25, and the lower circuit limit is 721.55.
The market cap is ₹83.13 Cr, and the PE ratio (TTM) is 171.35.
The PB ratio is 3.61, industry P/E is 184.43 .
ROE is 2.21, EPS is 4.85, book value is 235.66
In Sep 2023, Revenue is ₹746145000.00, and Profit is ₹66026000.00. In Jun 2023, Revenue is ₹837412000.00, and Profit is ₹79000000.00.
The company, Shilpa Medicare Limited, was listed in Dec 2009 and belongs to the Pharmaceuticals industry. Its NSE symbol is SHILPAMED.
As of latest available update, promoters hold 50.01%, the public holds 49.99%, and Employee Trusts holds 0.00.
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.